World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
59
Citations
20538
World Ranking
3202
National Ranking
1393

Overview

Alexander Marson is affiliated with the University of California, San Francisco in the United States. Their research primarily focuses on immunology, molecular biology, and oncology, with an emphasis on T-cell biology and immune system interactions.

Their recent published papers include:

  • Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis, 2021, Cell
  • Evaluation of SARS-CoV-2 serology assays reveals a range of test performance, 2020, Nature Biotechnology
  • Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence, 2022, Cancer Cell
  • CRISPR activation and interference screens decode stimulation responses in primary human T cells, 2022, Science
  • Test performance evaluation of SARS-CoV-2 serological assays, 2020, bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors working with Marson include:

  • Theodore L. Roth
  • Zhongmei Li
  • Brian R. Shy
  • Eric Shifrut
  • Chun Ye

The scientist publishes regularly in several research venues, notably:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature
  • Nature Biotechnology
  • Zenodo (CERN European Organization for Nuclear Research)
  • Cell Reports

Marson's work spans several main fields of study:

  • Immunology and Microbiology
  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Within these fields, their contributions focus on specific subfields including:

  • Immunology
  • Molecular Biology
  • Oncology
  • Genetics
  • Epidemiology

Key topics addressed in their research comprise:

  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • T-cell and B-cell Immunology
  • CRISPR and Genetic Engineering
  • Single-cell and spatial transcriptomics
  • Immunotherapy and Immune Responses
  • HIV Research and Treatment

Best Publications

  • Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants

    Kyle Kai How Farh;Alexander Marson;Jiang Zhu;Markus Kleinewietfeld

  • Connecting microrna genes to the core transcriptional regulatory circuitry of embryonic stem cells

    Rudolph Jaenisch;Richard A. Young;Alexander Marson;Stuart Levine

  • Multiplexed droplet single-cell RNA-sequencing using natural genetic variation

    Hyun Min Kang;Meena Subramaniam;Sasha Targ;Michelle Nguyen

  • Foxp3 occupancy and regulation of key target genes during T-cell stimulation

    Alexander Marson;Karsten Kretschmer;Garrett M. Frampton;Elizabeth S. Jacobsen

  • Reprogramming human T cell function and specificity with non-viral genome targeting

    Theodore L. Roth;Cristina Puig-Saus;Ruby Yu;Ruby Yu;Eric Shifrut;Eric Shifrut

  • Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

    Kathrin Schumann;Steven Lin;Eric Boyer;Dimitre R. Simeonov

  • CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells.

    Levi J. Rupp;Kathrin Schumann;Kole T. Roybal;Rachel E. Gate

  • Revisiting IL-2: Biology and therapeutic prospects

    Abul K. Abbas;Eleonora Trotta;Dimitre R. Simeonov;Alexander Marson

  • Wnt signaling promotes reprogramming of somatic cells to pluripotency

    Alexander Marson;Ruth Foreman;Brett Chevalier;Steve Bilodeau

  • Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements

    Maxwell R Mumbach;Ansuman T Satpathy;Evan A Boyle;Chao Dai

  • Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function

    Eric Shifrut;Eric Shifrut;Julia Carnevale;Victoria Tobin;Victoria Tobin;Theodore L. Roth;Theodore L. Roth

  • Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis

    Nathan D. Mathewson;Orr Ashenberg;Itay Tirosh;Simon Gritsch;Simon Gritsch

  • A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.

    Ryan J Park;Tim Wang;Dylan Koundakjian;Judd F Hultquist

  • Discovery of stimulation-responsive immune enhancers with CRISPR activation

    Dimitre R. Simeonov;Benjamin G. Gowen;Mandy Boontanrart;Theodore L. Roth

  • Transcriptional role of cyclin D1 in development revealed by a genetic–proteomic screen

    Frédéric Bienvenu;Siwanon Jirawatnotai;Siwanon Jirawatnotai;Joshua E. Elias;Joshua E. Elias;Clifford A. Meyer

  • Landscape of stimulation-responsive chromatin across diverse human immune cells.

    Diego Calderon;Michelle L. T. Nguyen;Anja Mezger;Anja Mezger;Arwa Kathiria

  • Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms.

    Sheng Xiao;Nir Yosef;Jianfei Yang;Yonghui Wang

  • The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation.

    Michel DuPage;Gaurav Chopra;Jason Quiros;Wendy L. Rosenthal

  • Evaluation of SARS-CoV-2 serology assays reveals a range of test performance.

    Jeffrey D. Whitman;Joseph Hiatt;Cody T. Mowery;Brian R. Shy

  • CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells

    Levi Rupp;Kathrin Schumann;Kole T Roybal;Alexander Marson

Frequent Co-Authors

Nevan J. Krogan
Nevan J. Krogan University of California, San Francisco
Jeffrey A. Bluestone
Jeffrey A. Bluestone University of California, San Francisco
Jacob E. Corn
Jacob E. Corn ETH Zurich
Mark S. Anderson
Mark S. Anderson University of California, San Francisco
Jennifer A. Doudna
Jennifer A. Doudna University of California, Berkeley
K. Mark Ansel
K. Mark Ansel University of California, San Francisco
William J. Greenleaf
William J. Greenleaf Stanford University
Alan Ashworth
Alan Ashworth University of California, San Francisco
Mark J. Daly
Mark J. Daly Massachusetts General Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Genetics opens doors to a variety of career opportunities in healthcare, research, and related fields. For those interested in the healthcare industry but seeking alternative pathways, several online degrees and certifications can complement a background in genetics or provide viable career options on their own.

For example, professionals looking for flexible, entry-level positions might explore medical billing and coding online courses. These programs offer a fast track to working within healthcare practices and hospitals, focusing on administrative skills vital to the field.

If your interests lean toward patient care, consider exploring nursing colleges with high acceptance rates. Nursing degrees remain in high demand nationwide and can offer stable employment for those seeking a hands-on healthcare role.

Management-oriented students may opt for healthcare administration degree programs. These accelerated online degrees prepare graduates for leadership roles within clinics, hospitals, and research organizations.

For those mindful of cost, pursuing healthcare administration programs that offer affordability without compromising quality can be an excellent decision.

Ultimately, whether your passion lies in research or healthcare administration, a variety of online degrees and training programs can help you build a rewarding career aligned with your interests in genetics.

Best Scientists Citing Alexander Marson

Trending Scientists

Recently Published Articles